Introduction Emzumab, a brand of Omalizumab, is a breakthrough medication for severe allergic asthma, nasal polyps, and chronic idiopathic urticaria (CIU). Developed by Cipla, Emzumab offers significant relief to patients struggling with these conditions.
Omalizumab injection for asthma therapy
- Asthma Management: Effective for patients aged 6 and older with persistent asthma not controlled by inhaled corticosteroids. It targets IgE antibodies, reducing exacerbations and improving breathing.
- Nasal Polyps: Helps reduce polyp size and improve nasal airflow in adults requiring additional treatment beyond nasal corticosteroids.
- CIU Relief: Provides significant relief for patients aged 12 and older with CIU unresponsive to antihistamines.
Administration and Dosage: Emzumab is administered subcutaneously with doses tailored to the patient’s condition, weight, and IgE levels. Typical dosages range from 75 mg to 600 mg every 2-4 weeks, depending on the condition being treated.
Safety and Precautions
- Not intended for acute asthma attacks.
- Requires monitoring for hypersensitivity reactions.
- Gradual reduction of corticosteroids under medical supervision is recommended.
Global Export Services: As a leading pharmaceutical exporter, we supply Emzumab in bulk, adhering to the highest quality standards. Our global distribution network ensures that this essential medication is accessible worldwide, enhancing respiratory health across borders.
Buying Information: For those interested in the Omalizumab injection price in India or looking to buy Omalizumab 150mg injections, we offer competitive pricing and reliable shipping options. You can buy Omalizumab injection directly from India through our platform, ensuring timely delivery and quality assurance.
Conclusion:
Emzumab (Omalizumab) is a vital solution for managing severe asthma, nasal polyps, and CIU. For bulk purchases and more information, visit The Indian Pharma.
